Efficacy and safety results of patients with HCV genotype 2 or 3 infection treated with ombitasvir/paritaprevir/ritonavir and sofosbuvir with or without ribavirin (QUARTZ II‐III)

By  

JOURNAL OF VIRAL HEPATITIS (ELECTRONIC), Vol. 25, Iss. 2, 2018-02 ,pp. : 118-125

John Wiley & Sons Inc

Access to resources Recommend Favorite

Abdominal ultrasound in the intensive care unit: a 3-year survey on 400 patients

By Schacherer Doris   Klebl Frank   Goetz Daniela   Buettner Roland   Zierhut Stephanie   Schoelmerich Juergen   Langgartner Julia  

Intensive Care Medicine, Vol. 33, Iss. 5, 2007-05 ,pp. : 841-844

Springer Publishing Company

Access to resources Recommend Favorite

Recent increase in enterococci, viridans streptococci, Pseudomonas spp. and multiresistant strains among haematological patients, with a negative impact on outcome. Results of a 3-year surveillance study at a single institution

By Cattaneo Chiara   Casari Salvatore   Bracchi Francesca   Signorini Liana   Ravizzola Giuseppe   Borlenghi Erika   Re Alessandro   Manca Nino   Carosi Giampiero   Rossi Giuseppe  

Scandinavian Journal of Infectious Diseases, Vol. 42, Iss. 5, 2010-04 ,pp. : 324-332

Informa Healthcare

Access to resources Recommend Favorite

A single stent strategy in patients with lifestyle limiting claudication: 3‐year results from the Durability II trial

By  

CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, Vol. 86, Iss. 1, 2015-07 ,pp. : 164-170

John Wiley & Sons Inc

Access to resources Recommend Favorite

Safety of gadoxetate disodium: Results from the clinical phase II–III development program and postmarketing surveillance

By  

JOURNAL OF MAGNETIC RESONANCE IMAGING, Vol. 42, Iss. 3, 2015-09 ,pp. : 634-643

John Wiley & Sons Inc

Access to resources Recommend Favorite